drugset / Trial / NCT04423159
Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)
Completed
225 enrolled
Centre for Infectious Disease Research in Zambia
European and Developing Countries Clinical Trials Partnership (EDCTP) · collabJohns Hopkins University · collab
NaSingle-groupOpen-labelPrevention
Summary
The purpose of the study is to find out if individuals who received first and second dose of Oral Cholera Vaccine (OCV) in Lukanga Swamps, Central Province of Zambia have developed protection against future attacks to cholera. The investigators also want to investigate whether vitamin A deficiency and being HIV positive increases the chances of suffering from cholera.
Timeline
- Start
- 2016-10-16
- Primary completion
- 2020-10-31
- Completion
- 2020-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shanchol | Vaccine | 1.5 ml | Oral |